.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Deloitte
Queensland Health
Merck
Boehringer Ingelheim
UBS
Chinese Patent Office
Citi
Cerilliant
Medtronic

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075400

« Back to Dashboard
NDA 075400 describes FAMOTIDINE, which is a drug marketed by Perrigo, Sandoz, Mylan, Watson Labs, Hospira, Carlsbad, Apothecon, Fresenius Kabi Usa, Apotex, Ivax Sub Teva Pharms, Teva, Alembic Pharms Ltd, Dr Reddys Labs Ltd, Navinta Llc, Aurobindo Pharma Ltd, Wockhardt, Sun Pharm Inds, Lupin Ltd, Mylan Labs Ltd, Apotex Inc, Actavis Elizabeth, Athenex Inc, Perrigo R And D, Mylan Pharms Inc, Sun Pharm Inds Ltd, West-ward Pharms Int, Hi-tech Pharma Co, Novel Labs Inc, Abbvie, and Baxter Hlthcare, and is included in sixty-one NDAs. It is available from one hundred and nineteen suppliers. Additional details are available on the FAMOTIDINE profile page.

The generic ingredient in FAMOTIDINE is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and seventy drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.

Summary for 075400

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 075400

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FAMOTIDINE
famotidine
TABLET;ORAL 075400 ANDA L Perrigo Company 0113-0141 0113-0141-65 3 BLISTER PACK in 1 CARTON (0113-0141-65) > 10 TABLET in 1 BLISTER PACK
FAMOTIDINE
famotidine
TABLET;ORAL 075400 ANDA L. Perrigo Company 0113-2141 0113-2141-46 10 BLISTER PACK in 1 CARTON (0113-2141-46) > 1 TABLET in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength10MG
Approval Date:Mar 18, 2005TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Teva
Cipla
Express Scripts
McKinsey
Citi
Johnson and Johnson
Argus Health
Healthtrust
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot